15 Publications
2022
The bone–muscle connection in breast cancer: implications and therapeutic strategies to preserve musculoskeletal health
Ballinger, Tarah JThompson, William R and Guise, Theresa A
(pp. 1-9). 2022
2021
Exercise load monitoring: integrated approaches to advance the individualisation of exercise oncology
Carter, Stephen JBaranauskas, Marissa NBallinger, Tarah JRogers, Laura QMiller, Kathy D and Nabhan, Dustin C
Aug 2021
2020
Impact of Genetic Ancestry on Treatment Toxicity and Racial Disparities in Breast Cancer
Ballinger, Tarah JBallinger, Tarah JCunningham, Geneva MCunningham, Geneva MWu, XiWu, XiSchneider, Bryan P and Schneider, Bryan P
Current Breast Cancer Reports, 2020-05-12. | Journal Article
 
Patient‐reported outcomes in the Translational Breast Cancer Research Consortium
Bowen, Deborah JBowen, Deborah JBowen, Deborah JBowen, Deborah JBowen, Deborah JBowen, Deborah JBowen, Deborah JShinn, Eileen HShinn, Eileen HShinn, Eileen HShinn, Eileen HShinn, Eileen HShinn, Eileen HShinn, Eileen HGregrowski, SophieGregrowski, SophieGregrowski, SophieGregrowski, SophieGregrowski, SophieGregrowski, SophieGregrowski, SophieKimmick, GretchenKimmick, GretchenKimmick, GretchenKimmick, GretchenKimmick, GretchenKimmick, GretchenKimmick, GretchenDominici, Laura SDominici, Laura SDominici, Laura SDominici, Laura SDominici, Laura SDominici, Laura SDominici, Laura SFrank, Elizabeth SFrank, Elizabeth SFrank, Elizabeth SFrank, Elizabeth SFrank, Elizabeth SFrank, Elizabeth SFrank, Elizabeth SSmith, Karen LSmith, Karen LSmith, Karen LSmith, Karen LSmith, Karen LSmith, Karen LisaSmith, Karen LRocque, GabrielleRocque, GabrielleRocque, GabrielleRocque, GabrielleRocque, GabrielleRocque, GabrielleRocque, GabrielleRuddy, Kathryn JRuddy, Kathryn JRuddy, Kathryn JRuddy, Kathryn JRuddy, Kathryn JRuddy, Kathryn JRuddy, Kathryn JPollastro, TeriPollastro, TeriPollastro, TeriPollastro, TeriPollastro, TeriPollastro, TeriPollastro, TeriMelisko, MichelleMelisko, MichelleMelisko, MichelleMelisko, MichelleMelisko, MichelleMelisko, MichelleMelisko, MichelleBallinger, Tarah JBallinger, Tarah JBallinger, Tarah JBallinger, Tarah JBallinger, Tarah JBallinger, Tarah JBallinger, Tarah JFayanju, Oluwadamilola MFayanju, Oluwadamilola MFayanju, Oluwadamilola MFayanju, Oluwadamilola MFayanju, Oluwadamilola MFayanju, Oluwadamilola MFayanju, Oluwadamilola MWolff, Antonio CWolff, Antonio CWolff, Antonio CWolff, Antonio CWolff, Antonio CWolff, Antonio C and Wolff, Antonio C
Cancer, vol. 126, (no. 5), pp. 930, March 1, 2020. | Journal Article
2019
iMETX (Individualized Metabolic RX): An environmental intervention to increase energy expenditure in breast cancer survivors
Ballinger, Tarah JeanAlthouse, Sandra KOlsen, Timothy PMiller, Kathy and Sledge, Jeffrey
Journal of Clinical Oncology, vol. 37, (no. 15_suppl), pp. e23060, 2019-05-20. | Journal Article
2018
Association between HER2 positivity by HER2/CEP17 ratio and response to neoadjuvant HER2 targeted therapy
Rappazzo, Katherine CynthiaChen, HeidiBallinger, Tarah Jean and Abramson, Vandana Gupta
Journal of Clinical Oncology, vol. 36, (no. 15_suppl), pp. e12632, 2018-05-20. | Journal Article
 
Current Landscape of Targeted Therapies for Hormone-Receptor Positive, HER2 Negative Metastatic Breast Cancer
Ballinger, Tarah JBallinger, Tarah JMeier, Jason BMeier, Jason BJansen, Valerie M and Jansen, Valerie M
Frontiers in oncology, vol. 8, pp. 308, 2018-00-00. | Journal Article
 
iMETx (Individualized Metabolic Rx): Pilot study of an environmental intervention to increase energy expenditure among breast cancer survivors
Ballinger, Tarah JeanNelson, EmilyOlsen, TimothyMiller, Kathy and Sledge, Jeffrey
Journal of Clinical Oncology, vol. 36, (no. 15_suppl), pp. TPS10125, 2018-05-20. | Journal Article
 
Impact of primary breast cancer therapy on energetic capacity and body composition
Ballinger, Tarah JBallinger, Tarah JReddy, AnuragReddy, AnuragAlthouse, Sandra KAlthouse, Sandra KNelson, Emily MNelson, Emily MMiller, Kathy DMiller, Kathy DSledge, Jeffrey S and Sledge, Jeffrey S
Breast cancer research and treatment, vol. 172, (no. 2), pp. 452, 2018-Nov. | Journal Article
2017
Discerning the clinical relevance of biomarkers in early stage breast cancer
Ballinger, TarahBallinger, Tarah JBallinger, Tarah JKassem, NawalKassem, NawalKassem, NawalShen, FeiShen, FeiShen, FeiJiang, GuanglongJiang, GuanglongJiang, GuanglongSmith, Mary LSmith, MarySmith, Mary LouRailey, EldaRailey, EldaRailey, EldaHowell, JohnHowell, JohnHowell, JohnWhite, CarolWhite, Carol BWhite, Carol BSchneider, Bryan PSchneider, Bryan and Schneider, Bryan P
Breast cancer research and treatment, vol. 164, (no. 1), pp. 97, 2017-Jul. | Journal Article
 
Effect of bariatric surgery on breast tissue and biomarkers in obese women at increased risk for breast cancer
Ballinger, Tarah JeanBallinger, Tarah JeanBallinger, Tarah JeanBallinger, Tarah JeanBallinger, Tarah JeanMiller, KathyMiller, KathyMiller, KathyMiller, KathyMiller, KathyLudwig, KandiceLudwig, KandiceLudwig, KandiceLudwig, KandiceLudwig, KandiceBadve, Sunil SBadve, Sunil SBadve, Sunil SBadve, Sunil SBadve, Sunil SSelzer, DonSelzer, DonSelzer, DonSelzer, DonSelzer, DonZhang, YingZhang, YingZhang, YingZhang, YingZhang, YingStorniolo, Anna MariaStorniolo, Anna MariaStorniolo, Anna MariaStorniolo, Anna MariaStorniolo, Anna MariaMina, Lida AMina, Lida AMina, Lida AMina, Lida A and Mina, Lida A
Journal of Clinical Oncology, vol. 35, (no. 15_suppl), pp. TPS1592, 2017-05-20. | Journal Article
2016
Triple Negative Breast Cancer—Review of Current and Emerging Therapeutic Strategies
Ballinger, TarahBallinger, TarahKremer, JillKremer, JillMiller, Kathy and Miller, Kathy
Oncology & Hematology Review (US), vol. 12, (no. 2), pp. 89, 2016-00-00. | Journal Article
2015
Current HER2 Testing Recommendations and Clinical Relevance as a Predictor of Response to Targeted Therapy
Ballinger, Tarah JBallinger, TarahSanders, MelindaSanders, Melinda EAbramson, Vandana and Abramson, Vandana G
Clinical Breast Cancer, vol. 15, (no. 3), pp. 180, 2015. | Journal Article
 
Subtyping of triple‐negative breast cancer: Implications for therapy
Abramson, Vandana GAbramson, Vandana GLehmann, Brian DLehmann, Brian DBallinger, Tarah JBallinger, Tarah JPietenpol, Jennifer A and Pietenpol, Jennifer A
Cancer, vol. 121, (no. 1), pp. 16, January 1, 2015. | Journal Article
2014
Characterization of breast cancers with PI3K mutations in an academic practice setting using SNaPshot profiling
Abramson, Vandana GAbramson, Vandana GAbramson, VandanaCooper Lloyd, MCooper Lloyd, MCooper Lloyd, MBallinger, TarahBallinger, TarahBallinger, TarahSanders, MelindaSanders, Melinda ESanders, Melinda EDu, LipingDu, LipingDu, LipingLai, DarsonLai, DarsonLai, DarsonSu, ZengliuSu, ZengliuSu, ZengliuMayer, IngridMayer, IngridMayer, IngridLevy, MiaLevy, MiaLevy, MiaLaFrance, DeleciaLafrance, DeleciaLaFrance, Delecia RLafrance, Delecia RVnencak-jones, Cindy LVnencak-jones, CindyVnencak-Jones, Cindy LVnencak-Jones, CindyShyr, YuShyr, YuShyr, YuDahlman, Kimberly BDahlman, Kimberly BDahlman, KimberlyPao, WilliamPao, WilliamPao, WilliamArteaga, CarlosArteaga, Carlos L and Arteaga, Carlos L
Breast Cancer Research and Treatment, vol. 145, (no. 2), pp. 399, 20140600. | Journal Article